The company said: "Our standard review process triggered a pause to vaccination to allow review of safety data. This is a routine action which has to happen whenever there is a potentially unexplained illness in one of the trials, while it is investigated, ensuring we maintain the integrity of the trials."
Experts say that in large vaccine trials, such issues are routine and there is no need to worry.